Avg closing price
Price range

16 Cathie Wood Regeneron Pharmaceuticals, Inc. transactions

Avg closing price
Price range
Sold 40.0% shares (-285 Thousand shares) Q3 2021
Avg closing price $620.82
Price range $574.03 - $680.96
Sold 41.5% shares (-506 Thousand shares) Q2 2021
Avg closing price $506.62
Price range $472.80 - $558.54
Increased shares by 169.8% (+767 Thousand shares) Q1 2021
Avg closing price $486.87
Price range $446.73 - $548.20
New holding (+452 Thousand shares) Q4 2020
Avg closing price $539.80
Price range $478.30 - $607.98
Sold -89 shares Q2 2020
Avg closing price $567.62
Price range $493.32 - $643.92
Sold 99.3% shares (-13.1 Thousand shares) Q4 2019
Avg closing price $336.44
Price range $274.13 - $376.51
Sold 4.9% shares (-684 shares) Q1 2019
Avg closing price $411.79
Price range $372.08 - $439.57
Sold 40.1% shares (-9.32 Thousand shares) Q4 2018
Avg closing price $366.02
Price range $335.82 - $403.04
Increased shares by 25.1% (+4.66 Thousand shares) Q3 2018
Avg closing price $380.58
Price range $351.14 - $408.51
Increased shares by 458.9% (+15.3 Thousand shares) Q2 2018
Avg closing price $312.75
Price range $284.60 - $344.99
Increased shares by 20.4% (+564 shares) Q1 2018
Avg closing price $347.81
Price range $315.82 - $393.78
Increased shares by 23.8% (+530 shares) Q4 2017
Avg closing price $405.00
Price range $358.63 - $469.95
Increased shares by 80.8% (+997 shares) Q3 2017
Avg closing price $475.84
Price range $431.38 - $521.22
Increased shares by 78.8% (+544 shares) Q2 2017
Avg closing price $437.61
Price range $366.06 - $526.53
Increased shares by 10.9% (+68 shares) Q1 2017
Avg closing price $370.66
Price range $340.75 - $397.80
New holding (+622 shares) Q4 2016
Avg closing price $380.27
Price range $336.01 - $444.52

News about Regeneron Pharmaceuticals, Inc. and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!